Objective: The antibacterial characteristics of the platelet products against various microorganisms have been emphasized. Here we evaluated the antibacterial effectiveness of platelet rich plasma (PRP), platelet poor plasma (PPP), platelet-concentrated plasma (PCP), and noncoagulating platelet-derived factor concentrate (PFC) on Moraxella catarrhalis and Staphylococcus aureus in in vitro conditions.
Material and Methods: Platelet rich plasma (PRP), PPP, PCP, and PFC were prepared. The standard strains of M. catarrhalis and S. aureus were mixed with the platelet solutions in vitro. Following incubation, the growing colonies were counted. This was repeated thrice.
Results: The efficacies of PRP and PPP were found to be present against both bacteria in all dilutions. While PCP was effective only in the 1:1 dilution. No effectiveness of PFC was identified in any of the dilutions.
Conclusion: The determination of significant antibacterial effects of PRP and PPP against S. aureus and M. catarrhalis indicate that they can be used in addition to the management of acute and chronic sinusitis.
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Original Article |
| Authors | |
| Publication Date | August 1, 2018 |
| Published in Issue | Year 2018 Volume: 1 Issue: 2 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.